Arkema S.A. (ARKAY) Stock Price & Analysis
Arkema S.A. (ARKAY) — price $61.54 (-4.37%), as of the Nov 19, 2026 trading session; market cap $4.71B.
Educational signal · not a buy or sell recommendation · How to read this
Arkema S.A. · ARKAY
Arkema S.A. manufactures and sells specialty chemicals and advanced materials globally, operating through segments like Adhesive Solutions, Advanced Materials, Coating Solutions, and Intermediates. The company provides a diverse range of products for sectors including construction, automotive, renewable energies, and consumer goods.
Price as of Nov 19, 2026
Key Statistics
No MoonshotScore yet: we have not published a score for this company.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $61.54 | |
| Change on the day | -4.37% | |
| 52-week range | $56.28 – $79.36 | |
| Market capitalisation | $4.71B | — |
| Price / earnings (trailing) | 52.50 | |
| Shares traded on the day | 300 |
Price & events
Other perspectives
Council score for Arkema (ARKAY): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
4 lenses, 4 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 19, 2026
Munger's Mindset
Balance Sheet & Valuation
Read on: Nov 19, 2026
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
The Munger lens reads the current price as undervalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Arkema (ARKAY), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Arkema S.A. (ARKAY) is the company analyzed here. It employs 20,648 people and is led by Thierry Le Henaff. The market values it at $4.71B.
What are the financial strengths and risks for Arkema (ARKAY)?
Short answer · as of
The distress and quality screens read Altman Z 1.62 · Piotroski F 5. Trailing ratios: ROE 1.2% · ROA 1.8% · current ratio 1.59.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held ARKAY in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported ARKAY in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Arkema (ARKAY)?
Common Questions About ARKAY
These answers are editorial: 1 of these 8 answers is drawn from the ARKAY research dossier (written Jun 14, 2026 by gemini-2.5-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is ARKAY a good stock to buy?
Stock Expert AI does not rate ARKAY buy, sell or hold. Arkema S.A. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the ARKAY stock price today?
The last price recorded for Arkema S.A. (ARKAY), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What are the main risks for ARKAY as an OTC-traded ADR?
As an American Depositary Receipt (ADR) traded on the OTC Other tier, ARKAY faces several distinct risks. A primary concern is liquidity, as OTC markets generally have lower trading volumes and wider bid-ask spreads compared to major exchanges, making it potentially difficult to buy or sell shares efficiently.
What are the key factors to evaluate for ARKAY?
Evaluate ARKAY on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. Analysts target $87.00 (+41%). Expansion in Sustainable Materials: Arkema's focus on developing sustainable materials, such as bio-based polymers and recyclable adhesives, aligns with growing global demand and regulatory pressures for environmentally friendly products. Not financial advice.
How frequently does ARKAY data refresh on this page?
ARKAY's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven ARKAY's recent stock price performance?
Arkema S.A. (ARKAY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified portfolio across specialty chemicals and advanced materials. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ARKAY overvalued or undervalued right now?
The trailing P/E of Arkema S.A. (ARKAY) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research ARKAY before investing?
Before investing in Arkema S.A. (ARKAY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 11 figures on this page — 6 from Financial Modeling Prep (FMP) and 5 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com